Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

Is a lack of female participants skewing heart disease trial results?

Heart disease is one of the leading causes of death in men and women, but women are commonly underrepresented in clinical trials. Could this negatively impact the treatment of female patients, and if so, what is the industry doing to encourage more female participants to enrol?

Go Top